Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 29

FDA approve AVIBACTAM SODIUM; AZTREONAM

Comment Full text

TARO

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 37

FDA approve RISPERIDONE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 38

FDA approve NAPROXEN

Comment Full text

DECIPHERA PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 35

FDA approve VIMSELTINIB

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 36

FDA approve BROMFENAC SODIUM

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 34

FDA approve OXCARBAZEPINE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 37

FDA approve ATROPINE SULFATE

Comment Full text

RISING

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 37

FDA approve LINEZOLID

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 35

FDA approve OXCARBAZEPINE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 35

FDA approve ETHINYL ESTRADIOL; ETONOGESTREL

Comment Full text
  • Previous
  • 138
  • 139
  • 140
  • 141
  • 142
  • Next

Search

News categories

  • Technical Exchange News(9865)
  • Event(407)
  • SEC News(166953)
  • FDA Approval(9320)
  • Company Report(721)
  • Business News(110903)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin